Xiaolu Tao

Dr. Xiaolu Tao, is the Chief Development Officer. Prior to joining Harbour BioMed, Dr. Tao served as Head of Clinical Pharmacology & Bioassay at Cstone. Before moving back to China, Dr. Tao worked at BMS as Clinical Pharmacology Director in the therapeutic areas of immunology and oncology for multiple innovative products.